BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioMed X Launches EU Backed AI Precision Medicine Project With Barbados To Address Early Diabetic Kidney Disease

The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...

January 28, 2026 | News

Merz Therapeutics Submits XEOMIN For Paediatric Spasticity Indication Across Europe

Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced that it has completed the regulatory submission for XEOMIN®&...

January 27, 2026 | News

Imagine Devices Inc. Partners With Neotech Products To Advance Trinity Tube For Neonatal Critical Care

Imagine Devices Inc., a medical device company focused on advancing neonatal and pediatric critical care, announced a strategic partnership with Neotech Pr...

January 27, 2026 | News

Ellipses Pharma Limited In Licences First In Class B7H3 Targeted ADC From Innolake Biopharm Co. Ltd To Expand Global Oncology Pipeline

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced th...

January 26, 2026 | News

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation Strengthening Clinical Biomarker Capabilities

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced that its San Diego laboratory has achieved Colle...

January 23, 2026 | News

FluoGuide Submits FDA IND for FG001, Paving Way for First US Registration Trial in High Grade Glioma

FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing surgical outcomes in oncology by lighting up cancer...

January 23, 2026 | News

HistoIndex Partners With Houston Research Institute To Advance AI Enabled Diagnostics In MASH Care

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Insti...

January 22, 2026 | News

Exciva Raises EUR 51 Million Series B To Advance Phase Two Alzheimer’s Agitation Trial

Series B financing will support Exciva's Phase 2 clinical trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease (AD) ...

January 21, 2026 | News

Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad

As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...

January 19, 2026 | News

Zylox Tonbridge Accelerates Global Expansion With Strategic Acquisition Of Optimed

Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accel...

January 19, 2026 | News

Bio Sourcing And Zerion Pharma Secure Eurostars Funding To Develop Oral Trastuzumab For HER2 Breast Cancer

Bio‑Sourcing and Zerion Pharma A/S announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody...

January 16, 2026 | News

Fresenius Kabi And TQ Therapeutics Sign Strategic Agreement To Scale T Cell Manufacturing For Cell And Gene Therapy

Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under...

January 16, 2026 | News

Basecamp Research And NVIDIA Achieve 97 Percent Success In AI Designed Therapies With Programmable Gene Insertion

The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene therapies. ...

January 14, 2026 | News

WuXi Biologics Secures UK MHRA GMP Clearance For Wuxi Ophthalmic Manufacturing Sites

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...

January 14, 2026 | News

Stay Connected